Doxorubicin Plus Dual Checkpoint Blockade for Soft Tissue Sarcomas
Conditions: Metastatic Soft Tissue Sarcoma; Advanced Soft Tissue Sarcoma Intervention: Drug: doxorubicin with AGEN1884 and AGEN2034 Sponsors: University of Colorado, Denver; National Cancer Institute (NCI); Agenus Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials